Fortress Biotech
From Wikipedia, the free encyclopedia
 | |
| Company type | Public |
|---|---|
| Nasdaq: FBIO Russell 2000 Index component | |
| Industry | Biopharmaceuticals |
| Founded | 2006 |
| Founder | Dr. Lindsay Allan Rosenwald |
| Headquarters | |
Key people |
|
| Website | www.fortressbiotech.com |
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.[1][2][3]
The company was founded in 2006 under the name Coronado Biosciences, initially as an oncology company.[4][5] In 2011, it was announced that Coronado raised $47.4 million in funding. Shortly thereafter it became a public company by registering all of its private shares as common stock.[5] The company changed its name to Fortress Biotech in April 2015.[4]
In November 2019, Fortress Biotech was ranked number 10 in the 2019 Deloitte Technology Fast 500 annual rankings.[6][7]